|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Interplay Between Galanin and Leptin in the Hypothalamic Control of Feeding via Corticotropin-Releasing Hormone and Neuropeptide Y
1 Division of Endocrinology, University Hospital, Lausanne, Switzerland
2 Division of Hypertension, University Hospital, Lausanne, Switzerland
3 Laboratory of Pharmacology, Faculty of Pharmacy, Coimbra, Portugal
Over long periods, feeding and metabolism are tightly regulated at the central level. The total amount of nutrients ingested is thought to result from a delicate balance between orexigenic and anorexigenic factors expressed and secreted by specialized hypothalamic neuronal populations. We have developed a system of perifused hypothalamic neurons to characterize the relationships existing between the orexigenic peptide galanin and two other physiological modulators of feeding: neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). We demonstrated that galanin stimulates CRH and NPY secretion from hypothalamic neurons in a dose-dependent manner. Exposure to leptin for 24 h before galanin stimulation decreased NPY secretion by 30%, leaving the responsiveness of CRH neurons intact. These results suggest that CRH and NPY neurons participate to the intrahypothalamic signaling pathway of galanin, an observation that can explain the lower potency of galanin to stimulate food intake in vivo compared with NPY. The differential effects exerted by leptin on CRH and NPY suggest that there exists a subset of NPY neurons that are exquisitely sensitive to marked variations in leptin levels, and that the CRH neurons are less responsive to increases in leptin concentrations.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Chau-Van, M. Gamba, R. Salvi, R. C. Gaillard, and F. P. Pralong Metformin Inhibits Adenosine 5'-Monophosphate-Activated Kinase Activation and Prevents Increases in Neuropeptide Y Expression in Cultured Hypothalamic Neurons Endocrinology, February 1, 2007; 148(2): 507 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kakui, J. Tanaka, Y. Tabata, K. Asai, N. Masuda, T. Miyara, Y. Nakatani, F. Ohsawa, N. Nishikawa, M. Sugai, et al. Pharmacological Characterization and Feeding-Suppressive Property of FMS586 [3-(5,6,7,8-Tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea Hydrochloride], a Novel, Selective, and Orally Active Antagonist for Neuropeptide Y Y5 Receptor J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Salvi, E. Castillo, M.-J. Voirol, M. Glauser, J.-P. Rey, R. C. Gaillard, P. Vollenweider, and F. P. Pralong Gonadotropin-Releasing Hormone-Expressing Neurons Immortalized Conditionally Are Activated by Insulin: Implication of the Mitogen-Activated Protein Kinase Pathway Endocrinology, February 1, 2006; 147(2): 816 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Igaz, R. Salvi, J.-P. Rey, M. Glauser, F. P. Pralong, and R. C. Gaillard Effects of Cytokines on Gonadotropin-Releasing Hormone (GnRH) Gene Expression in Primary Hypothalamic Neurons and in GnRH Neurons Immortalized Conditionally Endocrinology, February 1, 2006; 147(2): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Schauble, K. Reichwald, W. Grassl, H. Bechstein, H.-C. Muller, A. Scherag, F. Geller, M. Utting, W. Siegfried, H. Goldschmidt, et al. Human Galanin (GAL) and Galanin 1 Receptor (GALR1) Variations Are Not Involved in Fat Intake and Early Onset Obesity J. Nutr., June 1, 2005; 135(6): 1387 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Burcelin, B. Thorens, M. Glauser, R. C. Gaillard, and F. P. Pralong Gonadotropin-Releasing Hormone Secretion from Hypothalamic Neurons: Stimulation by Insulin and Potentiation by Leptin Endocrinology, October 1, 2003; 144(10): 4484 - 4491. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |